Pathologic study of pandemic influenza A (H1N1) 2009 cases from India

Vijay N Shelke1, Raju M Kolhapure, Dilip Kadam

  • 1Department of Electron Microscopy and Histopath, Byramjee Jeejeebhoy Medical College and Hospital, Pune, India. 2009svijay@gmail.com

Pathology International
|December 24, 2011
PubMed

Insights

This study details the pathology of 46 fatal pandemic influenza A (H1N1) 2009 cases in India. Findings show diffuse alveolar damage in lungs and viral antigen in bronchiolar epithelium, comparable to Western studies.

Area of Science:

  • Pathology
  • Virology
  • Public Health

Background:

  • The 2009 pandemic influenza A (H1N1) virus spread globally, with India reporting its first case in May 2009.
  • Existing autopsy studies on human pandemic influenza pathology were predominantly from Western countries.

Purpose of the Study:

  • To describe the clinicopathologic features of fatal pandemic influenza A (H1N1) 2009 virus infection in Indian patients.
  • To compare findings with previous international autopsy studies.
  • To highlight the utility of postmortem needle biopsy.

Main Methods:

  • Examination of postmortem needle biopsy tissues from 46 confirmed fatal cases of pandemic influenza A (H1N1) 2009.
  • Histopathological analysis to identify tissue damage.
  • Immunohistochemistry to determine the distribution of viral antigens.

Main Results:

  • Diffuse alveolar damage was consistently observed in lung tissues.
  • Viral antigen was consistently present in the bronchiolar epithelium.
  • Findings were comparable to previous autopsy studies from Western countries.

Conclusions:

  • The clinicopathologic findings in Indian fatal cases of pandemic influenza A (H1N1) 2009 align with existing literature.
  • Postmortem needle biopsy is a valuable technique for investigating influenza pathology when full autopsies are not feasible.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...